These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31260889)

  • 1. Discovery of a novel 2,5-dihydroxycinnamic acid-based 5-lipoxygenase inhibitor that induces apoptosis and may impair autophagic flux in RCC4 renal cancer cells.
    Selka A; Doiron JA; Lyons P; Dastous S; Chiasson A; Cormier M; Turcotte S; Surette ME; Touaibia M
    Eur J Med Chem; 2019 Oct; 179():347-357. PubMed ID: 31260889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caffeic acid phenethyl ester and its amide analogue are potent inhibitors of leukotriene biosynthesis in human polymorphonuclear leukocytes.
    Boudreau LH; Maillet J; LeBlanc LM; Jean-François J; Touaibia M; Flamand N; Surette ME
    PLoS One; 2012; 7(2):e31833. PubMed ID: 22347509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Zileuton-Hydroxycinnamic Acid Hybrids: Synthesis and Structure-Activity Relationship towards 5-Lipoxygenase Inhibition.
    Chiasson AI; Robichaud S; Ndongou Moutombi FJ; Hébert MPA; Mbarik M; Surette ME; Touaibia M
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33066378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sinapic acid phenethyl ester as a potent selective 5-lipoxygenase inhibitor: Synthesis and structure-activity relationship.
    Touaibia M; Hébert MJG; Levesque NA; Doiron JA; Doucet MS; Jean-François J; Cormier M; Boudreau LH; Surette ME
    Chem Biol Drug Des; 2018 Nov; 92(5):1876-1887. PubMed ID: 29953727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy.
    Cai H; Huang X; Xu S; Shen H; Zhang P; Huang Y; Jiang J; Sun Y; Jiang B; Wu X; Yao H; Xu J
    Eur J Med Chem; 2016 Jan; 108():89-103. PubMed ID: 26638042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship of caffeic acid phenethyl ester analogs as new 5-lipoxygenase inhibitors.
    Doiron JA; Leblanc LM; Hébert MJ; Levesque NA; Paré AF; Jean-François J; Cormier M; Surette ME; Touaibia M
    Chem Biol Drug Des; 2017 Apr; 89(4):514-528. PubMed ID: 27717142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway.
    Matsuyama M; Yoshimura R; Mitsuhashi M; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T
    Oncol Rep; 2005 Jul; 14(1):73-9. PubMed ID: 15944770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular mechanism of the inhibition by licofelone of the biosynthesis of 5-lipoxygenase products.
    Fischer L; Hornig M; Pergola C; Meindl N; Franke L; Tanrikulu Y; Dodt G; Schneider G; Steinhilber D; Werz O
    Br J Pharmacol; 2007 Oct; 152(4):471-80. PubMed ID: 17704828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and evaluation of semi-synthetic triazole-containing caffeic acid analogues as 5-lipoxygenase inhibitors.
    De Lucia D; Lucio OM; Musio B; Bender A; Listing M; Dennhardt S; Koeberle A; Garscha U; Rizzo R; Manfredini S; Werz O; Ley SV
    Eur J Med Chem; 2015 Aug; 101():573-83. PubMed ID: 26197161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenolic acid phenethylesters and their corresponding ketones: Inhibition of 5-lipoxygenase and stability in human blood and HepaRG cells.
    Mbarik M; Poirier SJ; Doiron J; Selka A; Barnett DA; Cormier M; Touaibia M; Surette ME
    Pharmacol Res Perspect; 2019 Oct; 7(5):e00524. PubMed ID: 31523435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and evaluation of novel diaryl-1,5-diazoles derivatives bearing morpholine as potent dual COX-2/5-LOX inhibitors and antitumor agents.
    Li Z; Wang ZC; Li X; Abbas M; Wu SY; Ren SZ; Liu QX; Liu Y; Chen PW; Duan YT; Lv PC; Zhu HL
    Eur J Med Chem; 2019 May; 169():168-184. PubMed ID: 30877972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and biological evaluation of novel 1,4-benzoquinone and related resorcinol derivatives that inhibit 5-lipoxygenase.
    Filosa R; Peduto A; Aparoy P; Schaible AM; Luderer S; Krauth V; Petronzi C; Massa A; de Rosa M; Reddanna P; Werz O
    Eur J Med Chem; 2013 Sep; 67():269-79. PubMed ID: 23871907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho-associated kinase 1 inhibition is synthetically lethal with von Hippel-Lindau deficiency in clear cell renal cell carcinoma.
    Thompson JM; Nguyen QH; Singh M; Pavesic MW; Nesterenko I; Nelson LJ; Liao AC; Razorenova OV
    Oncogene; 2017 Feb; 36(8):1080-1089. PubMed ID: 27841867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E₂ synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin.
    Schaible AM; Traber H; Temml V; Noha SM; Filosa R; Peduto A; Weinigel C; Barz D; Schuster D; Werz O
    Biochem Pharmacol; 2013 Aug; 86(4):476-86. PubMed ID: 23623753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-Activity Relationship Studies of New Sinapic Acid Phenethyl Ester Analogues Targeting the Biosynthesis of 5-Lipoxygenase Products: The Role of Phenolic Moiety, Ester Function, and Bioisosterism.
    Touaibia M; Faye DC; Doiron JA; Chiasson AI; Blanchard S; Roy PP; Surette ME
    J Nat Prod; 2022 Jan; 85(1):225-236. PubMed ID: 34995066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Lipoxygenase inhibitors induce potent anti-proliferative and cytotoxic effects in human tumour cells independently of suppression of 5-lipoxygenase activity.
    Fischer AS; Metzner J; Steinbrink SD; Ulrich S; Angioni C; Geisslinger G; Steinhilber D; Maier TJ
    Br J Pharmacol; 2010 Oct; 161(4):936-49. PubMed ID: 20860670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Treatment with CCI779 and SB203580 Induces Cellular Senescence in Renal Cell Carcinoma Cell Line via p53 Pathway.
    Chauhan A; Ojha R; Semwal DK; Mishra SP; Semwal RB
    Anticancer Agents Med Chem; 2017 Nov; 17(11):1545-1554. PubMed ID: 28270077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Hydroxycinnamic Acid Esters as Novel 5-Lipoxygenase Inhibitors That Affect Leukotriene Biosynthesis.
    Boudreau LH; Lassalle-Claux G; Cormier M; Blanchard S; Doucet MS; Surette ME; Touaibia M
    Mediators Inflamm; 2017; 2017():6904634. PubMed ID: 28680195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel di-tertiary-butyl phenylhydrazones as dual cyclooxygenase-2/5-lipoxygenase inhibitors: synthesis, COX/LOX inhibition, molecular modeling, and insights into their cytotoxicities.
    Ghatak S; Vyas A; Misra S; O'Brien P; Zambre A; Fresco VM; Markwald RR; Swamy KV; Afrasiabi Z; Choudhury A; Khetmalas M; Padhye S
    Bioorg Med Chem Lett; 2014 Jan; 24(1):317-24. PubMed ID: 24295787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further studies on ethyl 5-hydroxy-indole-3-carboxylate scaffold: design, synthesis and evaluation of 2-phenylthiomethyl-indole derivatives as efficient inhibitors of human 5-lipoxygenase.
    Peduto A; Bruno F; Dehm F; Krauth V; de Caprariis P; Weinigel C; Barz D; Massa A; De Rosa M; Werz O; Filosa R
    Eur J Med Chem; 2014 Jun; 81():492-8. PubMed ID: 24871899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.